The potential role of microvesicles in mesenchymal stem cell-based therapy

Stem Cells and Development

Volumn 22, Issue 6, 2013, Pages 841-844

  Huang, Yong Can ^a,b   Parolini, Ornella ^c   Deng, Li ^a  

^a SICHUAN UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c Fondazione Poliambulanza Istituto Ospedaliero   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MARROW; CELL COMMUNICATION; CELL FUNCTION; CELL REGENERATION; CELL SURVIVAL; CELL THERAPY; CELL TYPE; CELL VACUOLE; ENDOTHELIAL PROGENITOR CELL; HUMAN; LETTER; MEMBRANE VESICLE; MESENCHYMAL STEM CELL; MICROVESICLE; PARACRINE SIGNALING; PRIORITY JOURNAL; ULTRACENTRIFUGATION;

ANIMALS; BONE MARROW CELLS; CELL PROLIFERATION; CYTOPLASMIC VESICLES; FEMALE; HUMANS; MESENCHYMAL STROMAL CELLS; NEOPLASMS;

EID: 84876273263     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0631     Document Type: Letter

References (39)

1. Al-Nedawi K, B Meehan, RS Kerbel, AC Allison and J Rak. (2009). Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci U S A 106:3794-3799.
2. Muralidharan-Chari V, JW Clancy, A Sedgwick and C D'Souza-Schorey. (2010). Microvesicles: mediators of extra-cellular communication during cancer progression. J Cell Sci 123:1603-1611.
3. Pap E, E Pallinger, M Pasztoi and A Falus. (2009). Highlights of a new type of intercellular communication: microvesicle-based information transfer. Inflamm Res 58:1-8.
4. Inal JM, EA Ansa-Addo, D Stratton, S Kholia, SS Antwi-Baffour, S Jorfi and S Lange. (2012). Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz) 60:107-121.
5. Waldenstrom A, N Genneback, U Hellman and G Ronquist. (2012). Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells. PLoS One 7:e34653.
6. Fonsato V, F Collino, MB Herrera, C Cavallari, MC Dereg-ibus, B Cisterna, S Bruno, R Romagnoli, M Salizzoni, C Tetta and G Camussi. (2012). Human liver stem cell-derived mi-crovesicles inhibit hepatoma growth in SCID mice by de-livering antitumor micro RNAs. Stem Cells 30:1985-1998.
7. Biancone L, S Bruno, MC Deregibus, C Tetta and G Camussi. (2012). Therapeutic potential of mesenchymal stem cell-derived microvesicles. Nephrol Dial Transplant 27:3037-3042.
8. Patel AN, V Vargas, P Revello and DA Bull. (2012). Mesenchymal stem cell population isolated from the sub-epithelial layer of umbilical cord tissue. Cell Transplant [Epub ahead of print]; DOI: 10.3727/096368912X655064.
9. Zhang HC, XB Liu, S Huang, XY Bi, HX Wang, LX Xie, YQ Wang, XF Cao, J Lv, et al. (2012). Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesisboth in vitro and in vivo. Stem Cells Dev 21:3289-3297.
10. Pittenger MF, AM Mackay, SC Beck, RK Jaiswal, R Douglas, JD Mosca, MA Moorman, DW Simonetti, S Craig and DR Marshak. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147.
11. Porada CD and G Almeida-Porada. (2010). Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 62:1156-1166.
12. Parolini O, F Alviano, GP Bagnara, G Bilic, HJ Buhring, M Evangelista, S Hennerbichler, B Liu, M Magatti, et al. (2008). Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26: 300-311.
13. Huang YC, ZM Yang, XH Chen, MY Tan, J Wang, XQ Li, HQ Xie and L Deng. (2009). Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev 5:247-255.
14. Huang YC, O Parolini, G La Rocca and L Deng. (2012). Umbilical cord versus bone marrow-derived mesenchymal stromal cells. Stem Cells Dev 21:2900-2903.
15. Dazzi F and NJ Horwood. (2007). Potential of mesenchymal stem cell therapy. Curr Opin Oncol 19:650-655.
16. Hwang NS, C Zhang, YS Hwang and S Varghese. (2009). Mesenchymal stem cell differentiation and roles in regener-ative medicine. Wiley Interdiscip Rev Syst Biol Med 1: 97-106.
17. Satija NK, VK Singh, YK Verma, P Gupta, S Sharma, F Afrin, M Sharma, P Sharma, RP Tripathi and GU Gurudutta. (2009). Mesenchymal stem cell-based therapy: a new para-digm in regenerative medicine. J Cell Mol Med 13:4385-4402.
18. Toma C, MF Pittenger, KS Cahill, BJ Byrne and PD Kessler. (2002). Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circu-lation 105:93-98.
19. Leung VY, D Chan and KM Cheung. (2006). Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction. Eur Spine J 15 Suppl 3: S406-S413.
20. Walter MN, KT Wright, HR Fuller, S Mac Neil and WE Johnson. (2010). Mesenchymal stem cell-conditioned me-dium accelerates skin wound healing: an in vitro study of fibroblast and keratinocyte scratch assays. Exp Cell Res 316:1271-1281.
21. Timmers L, SK Lim, IE Hoefer, F Arslan, RC Lai, AA van Oorschot, MJ Goumans, C Strijder, SK Sze, et al. (2011). Human mesenchymal stem cell-conditioned medium im-proves cardiac function following myocardial infarction. Stem Cell Res 6:206-214.
22. Osugi M, W Katagiri, R Yoshimi, T Inukai, H Hibi and M Ueda. (2012). Conditioned media from mesenchymal stem cells enhanced bone regeneration in rat calvarial bone de-fects. Tissue Eng Part A 18:1479-1489.
23. Bruno S, C Grange, MC Deregibus, RA Calogero, S Saviozzi, F Collino, L Morando, A Busca, M Falda, et al. (2009). Me-senchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 20:1053-1067.
24. Collino F, MC Deregibus, S Bruno, L Sterpone, G Aghemo, L Viltono, C Tetta and G Camussi. (2010). Microvesicles de-rived from adult human bone marrow and tissue specific mesenchymal stem cells shuttle selected pattern of mi RNAs. PLoS One 5:e11803.
25. Iglesias DM, R El-Kares, A Taranta, F Bellomo, F Emma, M Besouw, E Levtchenko, J Toelen, L van den Heuvel, et al. (2012). Stem cell microvesicles transfer cystinosin to human cystinotic cells and reduce cystine accumulation in vitro. PLoS One 7:e42840.
26. Mokarizadeh A, N Delirezh, A Morshedi, G Mosayebi, AA Farshid and K Mardani. (2012). Microvesicles derived from mesenchymal stem cells: potent organelles for induction of tolerogenic signaling. Immunol Lett 147:47-54.
27. Strassburg S, NW Hodson, PI Hill, SM Richardson and JA Hoyland. (2012). Bi-directional exchange of membrane components occurs during co-culture of mesenchymalstem cells and nucleus pulposus cells. PLoS One 7:e33739.
28. Gatti S, S Bruno, MC Deregibus, A Sordi, V Cantaluppi, C Tetta and G Camussi. (2011). Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transpl 26:1474-1483.
29. Bruno S, C Grange, F Collino, MC Deregibus, V Cantaluppi, L Biancone, C Tetta and G Camussi. (2012). Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 7:e33115.
30. Breitbach M, T Bostani, W Roell, Y Xia, O Dewald, JM Nygren, JW Fries, K Tiemann, H Bohlen, et al. (2007). Potential risks of bone marrow cell transplantation into in-farcted hearts. Blood 110:1362-1369.
31. Kunter U, S Rong, P Boor, F Eitner, G Muller-Newen, Z Djuric, CR van Roeyen, A Konieczny, T Ostendorf, et al. (2007). Mesenchymal stem cells prevent progressive experi-mental renal failure but maldifferentiate into glomerular adipocytes. J Am Soc Nephrol 18:1754-1764.
32. Huang YC, HM Zhu, JQ Cai, YZ Huang, J Xu, Y Zhou, XH Chen, XQ Li, ZM Yang and L Deng. (2012). Hypoxia inhibits the spontaneous calcification of bone marrow-derived mes-enchymal stem cells. J Cell Biochem 113:1407-1415.
33. Casiraghi F, G Remuzzi, M Abbate and N Perico. (2012). Multipotent mesenchymal stromal cell therapy and risk of malignancies. Stem Cell Rev [Epub ahead of print]; DOI: 10.1007/s12015-011-9345-4.
34. Tarte K, P Ame-Thomas, H Maby-El Hajjami, C Monvoisin, R Jean, T Lamy and T Fest. (2006). Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: Implications in follicular lymphoma pathogenesis. Blood 109:693-702.
35. Karnoub AE, AB Dash, AP Vo, A Sullivan, MW Brooks, GW Bell, AL Richardson, K Polyak, R Tubo and RA Weinberg. (2007). Mesenchymal stem cells within tumour stroma pro-mote breast cancer metastasis. Nature 449:557-563.
36. Suzuki K, RW Sun, M Origuchi, M Kanehira, T Takahata, J Itoh, A Umezawa, H Kijima, S Fukuda and Y Saijo. (2011). Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med 17:579-587.
37. Hung SP, MH Yang, KF Tseng and OK Lee. (2012). Hypoxia-induced secretion of TGF-beta 1 in mesenchymal stem cell promotes breast cancer cell progression. Cell Transplant [Epub ahead of print]; DOI: 10.3727/096368912X657954.
38. Bruno S, F Collino, MC Deregibus, C Grange, C Tetta and G Camussi. (2012). Microvesicles derived from human bone marrow mesenchymal stem cells inhibit tumor growth. Stem Cells Dev [Epub ahead of print]; DOI: 10.1089/scd. 2012.0304.
39. Lai RC, F Arslan, MM Lee, NS Sze, A Choo, TS Chen, M Salto-Tellez, L Timmers, CN Lee, et al. (2010). Exosome se-creted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4:214-222.